Brian K. Kaspar

Brian K. Kaspar

Auto-generated profile, based on publicly available information

Brian K. Kaspar

The Research Institute, Nationwide Children's Hospital, Columbus, OH, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2015 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ZHZoe C. Hesp
Zoe C. Hesp
EGEvan A. Goldstein
Evan A. Goldstein
CMCarlos J. Miranda
Carlos J. Miranda
BKBrain K. Kaspar
Brain K. Kaspar
DMDana McTigue
Dana McTigue
Adult progenitor cells proliferate in the acutely injured spinal cord and their progeny differentiate into new oligodendrocytes (OLs) that remyelinate spared axons. Whether this endogenous repair continues beyond the first week postinjury (wpi), however, is unknown. Identifying the duration of this response is essential for guiding therapies targeting improved recovery from spinal cord injury (SCI) by enhancing OL survival and/or remyelination. Here, we used two PDGFRα-reporter mouse lines and rats injected with a GFP-retrovirus to assess progenitor fate through 80 d after injury. Surprisingly, new OLs were generated as late as 3 months after injury and their processes ensheathed axons near and distal to the lesion, colocalized with MBP, and abutted Caspr+ profiles, suggesting newly formed myelin. Semithin sections confirmed stereotypical thin OL remyelination and few bare axons at 10 wpi, indicating that demyelination is relatively rare. Astrocytes in chronic tissue expressed the pro-OL differentiation and survival factors CNTF and FGF-2. In addition, pSTAT3+ NG2 cells were present through at least 5 wpi, revealing active signaling of the Jak/STAT pathway in these cells. The progenitor cell fate genes Sox11, Hes5, Id2, Id4, BMP2, and BMP4 were dynamically regulated for at least 4 wpi. Collectively, these data verify that the chronically injured spinal cord is highly dynamic. Endogenous repair, including oligodendrogenesis and remyelination, continues for several months after SCI, potentially in response to growth factors and/or transcription factor changes. Identifying and understanding spontaneous repair processes such as these is important so that beneficial plasticity is not inadvertently interrupted and effort is not exerted to needlessly duplicate ongoing spontaneous repair.

19 November 2014 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GTGretchen M. Thomsen
Gretchen M. Thomsen
GGGenevieve Gowing
Genevieve Gowing
JLJessica Latter
Jessica Latter
MCMaximus Chen
Maximus Chen
JVJean-Philippe Vit
Jean-Philippe Vit
CSClive N Svendsen
Clive N Svendsen
Sporadic amyotrophic lateral sclerosis (ALS) is a fatal disease with unknown etiology, characterized by a progressive loss of motor neurons leading to paralysis and death typically within 3–5 years of onset. Recently, there has been remarkable progress in understanding inherited forms of ALS in which well defined mutations are known to cause the disease. Rodent models in which the superoxide dismutase-1 (SOD1) mutation is overexpressed recapitulate hallmark signs of ALS in patients. Early anatomical changes in mouse models of fALS are seen in the neuromuscular junctions (NMJs) and lower motor neurons, and selective reduction of toxic mutant SOD1 in the spinal cord and muscle of these models has beneficial effects. Therefore, much of ALS research has focused on spinal motor neuron and NMJ aspects of the disease. Here we show that, in the SOD1G93Arat model of ALS, spinal motor neuron loss occurs presymptomatically and before degeneration of ventral root axons and denervation of NMJs. Although overt cell death of corticospinal motor neurons does not occur until disease endpoint, we wanted to establish whether the upper motor neuron might still play a critical role in disease progression. Surprisingly, the knockdown of mutant SOD1 in only the motor cortex of presymptomatic SOD1G93Arats through targeted delivery of AAV9–SOD1–shRNA resulted in a significant delay of disease onset, expansion of lifespan, enhanced survival of spinal motor neurons, and maintenance of NMJs. This datum suggests an early dysfunction and thus an important role of the upper motor neuron in this animal model of ALS and perhaps patients with the disease.

5 February 2021 in Neurobiology of Aging
Verified
Journal Article
Open access
DCDeepti Chugh
Deepti Chugh
CIChitra C. Iyer
Chitra C. Iyer
PBPrameela Bobbili
Prameela Bobbili
ABAnton J. Blatnik
Anton J. Blatnik
BKBrian K. Kaspar
Brian K. Kaspar
WAWilliam david Arnold
William david Arnold
Sarcopenia, or pathological loss of muscle mass and strength during aging, is an important contributor to loss of physical function in older adults. Sarcopenia is a multifactorial syndrome associated with intrinsic muscle and upstream neurological dysfunction. Exercise is well-established as an effective intervention for sarcopenia, but less is known about the long-term neurobiological impact of exercise. The goals of this study were to investigate the effects of exercise, alone or in combination with follistatin (FST) overexpression (antagonist of myostatin), on neuromuscular junction transmission and motor unit numbers in mice between the age of 22 and 27 months, ages at which prior studies have demonstrated that some motor unit loss is already evident. C57BL/6J mice underwent baseline assessment and were randomized to housing with or without voluntary running wheels and injection with adeno-associated virus to overexpress FST or vehicle. Groups for comparison included sedentary and running with and without FST. Longitudinal assessments showed significantly increased muscle mass and contractility in the 'running plus FST' group, but running, with and without FST, showed no effect on motor unit degeneration. In contrast, running, with and without FST, demonstrated marked improvement of neuromuscular junction transmission stability.

1 May 2016 in Molecular Therapy
Verified
Journal Article
Open access
JMJerry R. Mendell
Jerry R. Mendell
ZSZarife Sahenk
Zarife Sahenk
MHMark Hogan
Mark Hogan
SASamiah Al-Zaidy
Samiah Al-Zaidy
KFKevin Flanigan
Kevin Flanigan
BKBrian K. Kaspar
Brian K. Kaspar

1 January 2017
Verified
Book Chapter
Closed access
KFK.D. Foust
K.D. Foust
BKB.K. Kaspar
B.K. Kaspar

1 October 2012 in Neuromuscular Disorders
Verified
Journal Article
Closed access
ABArthur Burghes
Arthur Burghes
VMVicki McGovern
Vicki McGovern
PPP. Porensky
P. Porensky
SDS. Duque
S. Duque
ABA. Bevan
A. Bevan
BKB. Kaspar
B. Kaspar